Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors)
- 1 July 2007
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 20 (7), 802-810
- https://doi.org/10.1038/modpathol.3800825
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Promoter hypermethylation and global hypomethylation are independent epigenetic events in lymphoid leukemogenesis with opposing effects on clinical outcomeLeukemia, 2006
- Epigenetic alterations in neuroendocrine tumors: methylation of RAS-association domain family 1, isoform A and p16 genes are associated with metastasisLaboratory Investigation, 2005
- Causes and consequences of DNA hypomethylation in human cancerBiochemistry and Cell Biology, 2005
- Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesisOncogene, 2004
- Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylationCancer Science, 2004
- Aberrant Hypermethylation of Tumor Suppressor Genes in Pancreatic Endocrine NeoplasmsAnnals of Surgery, 2003
- A 5‐decade analysis of 13,715 carcinoid tumorsCancer, 2003
- Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinomaGenes, Chromosomes and Cancer, 2002
- Similar integration but different stability of Alus and LINEs in the human genomeGene, 2001
- The Role of DNA Methylation in Mammalian EpigeneticsScience, 2001